These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3360112)

  • 1. [Pharmacokinetics of verapamil and its N-dealkylated metabolites in patients with chronic ischemic heart disease undergoing long-term monotherapy].
    Rumiantsev DO; Piotrovskiĭ VK; Metelitsa VI; Riabokon' OS; Kokurina EV
    Farmakol Toksikol; 1988; 51(1):66-70. PubMed ID: 3360112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition kinetics and urinary excretion of verapamil and some of its primary metabolites after oral administration in patients with angina pectoris.
    Piotrovskii VK; Rumiantsev DO; Nikolenko SA; Riabokon OS; Metelitsa VI
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):4-11. PubMed ID: 3957489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
    Abernethy DR; Egan JM; Dickinson TH; Carrum G
    J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic phenobarbital on verapamil disposition in humans.
    Rutledge DR; Pieper JA; Mirvis DM
    J Pharmacol Exp Ther; 1988 Jul; 246(1):7-13. PubMed ID: 3392664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels and urinary excretion of verapamil, norverapamil, N-dealkylverapamil (D617), N-dealkylnorverapamil (D620) following oral administration of a slow-release preparation.
    Barbieri E; Padrini R; Piovan D; Toffoli M; Cargnelli G; Trevi G; Ferrari M
    Int J Clin Pharmacol Res; 1985; 5(2):99-107. PubMed ID: 4018947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of verapamil and norverapamil during long-term oral therapy.
    Tartaglione TA; Pieper JA; Lopez LL; Mehta J
    Res Commun Chem Pathol Pharmacol; 1983 Apr; 40(1):15-27. PubMed ID: 6867470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients.
    Brockmeyer NH; Tillmann I; Mertins L; Barthel B; Goos M
    Eur J Med Res; 1997 Sep; 2(9):377-83. PubMed ID: 9300934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic parameters of verapamil and its active metabolite norverapamil in patients with hepatopathy.
    Vlcek J; Macek K; Hůlek P; Brátová M; Fendrich Z
    Arzneimittelforschung; 1995 Feb; 45(2):146-9. PubMed ID: 7710436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of verapamil LI 120 mg 3 times a day and verapamil LP 120 mg twice a day in stable exertion-induced angina. A multicenter study].
    Belin A; Prost PL; Mercadier G; Grollier G; Lablanche JM
    Ann Cardiol Angeiol (Paris); 1995 Sep; 44(7):365-71. PubMed ID: 8561442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of glycerin trinitrate (nitroglycerin) after sublingual administration in patients with chronic ischemic heart disease].
    Blagodatskikh SV; Piotrovskiĭ VK; Metelits VI; Riabokon' OS; Martsevich SIu
    Farmakol Toksikol; 1987; 50(6):59-63. PubMed ID: 3125063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of oral verapamil therapy on antipyrine clearance.
    Rumiantsev DO; Piotrovskii VK; Riabokon OS; Slastnikova ID; Kokurina EV; Metelitsa VI
    Br J Clin Pharmacol; 1986 Nov; 22(5):606-9. PubMed ID: 3790408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective first-pass metabolism of verapamil in the small intestine and liver in rats.
    Hanada K; Ikemi Y; Kukita K; Mihara K; Ogata H
    Drug Metab Dispos; 2008 Oct; 36(10):2037-42. PubMed ID: 18617604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging effects on stereoselective pharmacokinetics and pharmacodynamics of verapamil.
    Schwartz JB; Troconiz IF; Verotta D; Liu S; Capili H
    J Pharmacol Exp Ther; 1993 May; 265(2):690-8. PubMed ID: 8496816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized prospective controlled study of the metabolism and hepatotoxicity of halothane in humans.
    Cousins MJ; Gourlay GK; Knights KM; Hall PD; Lunam CA; O'Brien P
    Anesth Analg; 1987 Apr; 66(4):299-308. PubMed ID: 3565792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The mono-oxygenase enzyme system of the liver in patients with true eczema].
    Ashirmetov AKh; Akovbian VA; Krakovskiĭ ME; Tikhonova NN
    Vestn Dermatol Venerol; 1990; (4):46-9. PubMed ID: 2143879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil.
    Krecic-Shepard ME; Barnas CR; Slimko J; Schwartz JB
    Clin Pharmacol Ther; 2000 Sep; 68(3):286-92. PubMed ID: 11014410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates.
    Lemma GL; Wang Z; Hamman MA; Zaheer NA; Gorski JC; Hall SD
    Clin Pharmacol Ther; 2006 Mar; 79(3):218-30. PubMed ID: 16513446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability, pharmacokinetics, and clinical effects of an oral preparation of etoposide.
    Stewart DJ; Nundy D; Maroun JA; Tetreault L; Prior J
    Cancer Treat Rep; 1985 Mar; 69(3):269-73. PubMed ID: 3884152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.